Valuation: China Isotope & Radiation Corporation

Market Cap 4.48B 5.2B 663M 576M 535M 493M 929M 63.27B 945M 6.33B 2.48B 31.42B 2.49B 2.43B 106B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 4.6B 5.34B 680M 591M 549M 506M 953M 64.95B 971M 6.5B 2.54B 32.26B 2.55B 2.5B 108B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
07-06 China Isotope to Form JV With Associate MT
07-03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
06-18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
06-18 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
05-27 China Isotope Proposes Auditor Change MT
05-26 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
03-28 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
03-27 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
03-27 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-20 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
03-14 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
03-14 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
03-02 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
1 day+0.37%
1 week-0.91%
Current month-6.80%
1 month-5.56%
3 months-13.89%
6 months-22.92%
Current year-19.26%
1 week 16.09
Extreme 16.09
17.99
1 month 16.09
Extreme 16.09
18.7
Current year 16.09
Extreme 16.09
24.28
1 year 15.2
Extreme 15.2
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
29.95
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 02/08/2024
Corporate Secretary - 30/08/2024
Corporate Secretary - 30/08/2024
Director TitleAgeSince
Director/Board Member 57 22/02/2017
Director/Board Member 54 28/06/2019
Director/Board Member 54 30/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-0.91%-0.67%+9.76% 663M
+5.75%+1.43%+237.13%+292.45% 20.2B
-0.77%+2.00%-43.32%-26.92% 9.76B
+1.00%-2.63%+40.59%+14.84% 6.58B
+6.71%+2.85%+255.36%-21.43% 6.28B
+2.01%+2.29%-15.04%-19.06% 5.66B
+3.21%+2.81%-45.46% - 4.55B
+1.02%+4.41%-18.69%-31.72% 4.21B
-6.84%-15.30%+57.97%+75.47% 3.86B
+2.20%+2.20%-17.00%-41.94% 2.83B
Average +1.47%-0.33%+45.09%+27.94% 6.46B
Weighted average by Cap. +2.60%-1.02%+93.56%+92.39%

Financials

2024 2025
Net sales 7.57B 8.78B 1.12B 973M 903M 833M 1.57B 107B 1.6B 10.7B 4.19B 53.11B 4.21B 4.11B 179B 7.19B 8.34B 1.06B 923M 857M 791M 1.49B 101B 1.52B 10.15B 3.97B 50.39B 3.99B 3.9B 169B
Net income 407M 472M 60.13M 52.23M 48.5M 44.73M 84.25M 5.74B 85.78M 574M 225M 2.85B 226M 221M 9.59B 327M 380M 48.41M 42.05M 39.05M 36.01M 67.84M 4.62B 69.07M 462M 181M 2.3B 182M 178M 7.72B
Net Debt -109M -126M -16.11M -13.99M -12.99M -11.98M -22.57M -1.54B -22.98M -154M -60.22M -764M -60.49M -59.16M -2.57B 119M 138M 17.57M 15.26M 14.17M 13.07M 24.62M 1.68B 25.07M 168M 65.7M 833M 65.99M 64.54M 2.8B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
31/07/26 HK$16.31 +0.37% 32,800
30/07/26 HK$16.25 0.00% 201,000
29/07/26 HK$16.25 -0.79% 221,400
28/07/26 HK$16.38 -2.85% 216,800
27/07/26 HK$16.86 +2.43% 70,800

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock